Skip to main content
. 2004 Jan 5;141(2):205–208. doi: 10.1038/sj.bjp.0705623

Table 3.

Frequencies for CYP2C9 variant alleles in patients with acute gastrointestinal bleeding secondary to NSAID and in control individuals who reported no adverse effects during NSAID therapy

Variant allele Bleeding patients num, (%) Control patients num, (%) Crude OR 95% CI P
CYP2C9*1 128 (68.1) 193 (77.8) 0.61 0.39–0.95 0.022
CYP2C9*2 44 (23.4) 34 (13.7) 1.92 1.14–3.25 0.009
CYP2C9*3 16 (8.5) 21 (8.5) 1.01 0.48–2.08 0.987
Total 188 (100) 248 (100)